Comparison of human respiratory syncytial virus A2 and 8/60 fusion glycoprotein gene sequences and mapping of sub-group specific antibody epitopes

Journal of Medical Virology

Volumn 63, Issue 2, 2001, Pages 168-177

  Connor, A L ^a   Bevitt, D J ^a   Toms, G L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antigenic variation; HRSV sub groups; Neutralising antibodies; Site directed mutagenesis

Indexed keywords

GLYCOPROTEIN; HYBRID PROTEIN; NEUTRALIZING ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; COMPARATIVE STUDY; EPITOPE MAPPING; GENE MAPPING; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PASSIVE IMMUNIZATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SITE DIRECTED MUTAGENESIS; STRAIN DIFFERENCE; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; EPITOPE MAPPING; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MUTAGENESIS, SITE-DIRECTED; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VARIATION (GENETICS); VIRAL FUSION PROTEINS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0035126288     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(20000201)63:2<168::AID-JMV1012>3.0.CO;2-U     Document Type: Article

References (36)

1. Molecular cloning and sequencing of the F and 22K membrane protein genes of the RSS-2 strain of respiratory syncytial virus
2. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus
3. Evolution of subgroup A respiratory syncytial, virus: Evidence for progressive accumulation of amino acid changes in the attachment protein
4. An inexpensive and simple method for DNA purifications on silica particles
5. Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins
6. Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction
7. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus
8. Cross-reactive and group-specific immune responses to a neutralizing epitope of the human respiratory syncytial virus fusion protein
9. Neutralization of animal viruses
10. Respiratory syncytial virus fusion glycoprotein nucleotide sequence of mRNA, identification of cleavage activation and amino acid sequence of N-terminus of F1 sub-unit
11. Respiratory syncytial virus (RSV) infections and influenza-A infections in the hospitalized elderly
12. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
13. Risk of primary infection and reinfection with respiratory syncytial virus
14. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high risk infants
15. Respiratory syncytial virus infections within families
16. Respiratory syncytial virus infections, reinfections and immunity; a prospective longitudinal study in children
17. The fusion glycoproteins of human respiratory syncytial virus subgroups A and B: Sequence conservation provides a structural basis for antigenic relatedness
18. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: Evaluation of the contributions of F and G glycoproteins to immunity
19. The G glycoprotein of human respiratory syncytial virus of subgroups A and B: Extensive sequence divergence between antigenically related proteins
20. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children
21. Nucleotide sequence of the fusion and phosphoprotein genes of human respiratory syncytial (RS) virus Long strain: Evidence of subtype genetic heterogeneity
22. The binding of neutralising monocolonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in E. coli
23. Expression of the F gene from respiratory syncytial virus in Escherichia coli: Mapping of a fusion inhibiting epitope
24. Respiratory syncytial virus
25. Two distinct subtypes of human respiratory virus
26. Variation in the fusion glycoprotein gene of human respiratory syncytial virus subgroup A
27. Antigenic variations of respiratory syncytial virus in recurrent infections
28. The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection of BALB/c mice
29. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus
30. Comparative virulence of respiratory syncytial virus subgroups A and B
31. Monoclonal antibodies protect against respiratory syncytial virus infection in mice
32. Respiratory syncytial virus and other pediatric respiratory virus infections
33. IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity
34. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: Evaluation of antibody persistence and possible disease enchancement
35. Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus
36. Community respiratory virus-infections among hospitalized adult bone-marrow transplant recipients